Stryker (SYK) EBT Margin (2009 - 2026)
Stryker (SYK) reported EBT Margin of 14.12% for Q1 2026, up 110.0% year-over-year from 6.72% in Q1 2025, and down 40.61% quarter-over-quarter from 23.78% in Q4 2025.
Stryker (SYK) EBT Margin (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of EBT Margin data on file, last reported at 14.12% in Q1 2026.
- EBT Margin for Q1 2026 came in at 14.12%, up 110.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 18.2% (up 385.0% YoY), and the FY2025 annual result was 17.97%, up 252.0% from the prior year.
- EBT Margin retreated to 14.12% in Q1 2026 per SYK's latest filing, from 23.78% in the prior quarter.
- Over five years, EBT Margin peaked at 23.78% in Q4 2025 and troughed at 8.2% in Q4 2024.
- A 5-year average of 16.29% and a median of 16.99% in 2025 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2024 and 2025: EBT Margin sank 1288 bps in 2024, then jumped 1557 bps in 2025.
- A 5-year view of EBT Margin shows it stood at 14.63% in 2022, then jumped by 44 bps to 21.08% in 2023, then sank by 61 bps to 8.2% in 2024, then jumped by 190 bps to 23.78% in 2025, then slumped by 41 bps to 14.12% in 2026.
- Business Quant data shows SYK's EBT Margin at 14.12% in Q1 2026, 23.78% in Q4 2025, and 16.99% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 27.84% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 9.84% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 22.61% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 19.17% |
| 10 | Zimmer Biomet Holdings | 17.27 Bn | 16.86 Bn | 1.51 Bn | 14.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.12% |
| Dec 31, 2025 | 23.78% |
| Sep 30, 2025 | 16.99% |
| Jun 30, 2025 | 16.87% |
| Mar 31, 2025 | 13.02% |
| Dec 31, 2024 | 8.20% |
| Sep 30, 2024 | 18.98% |
| Jun 30, 2024 | 18.41% |
| Mar 31, 2024 | 17.60% |
| Dec 31, 2023 | 21.08% |
| Sep 30, 2023 | 17.70% |
| Jun 30, 2023 | 17.99% |
| Mar 31, 2023 | 14.21% |
| Dec 31, 2022 | 14.63% |
| Sep 30, 2022 | 18.22% |
| Jun 30, 2022 | 16.02% |
| Mar 31, 2022 | 9.03% |
| Dec 31, 2021 | 16.10% |
| Sep 30, 2021 | 11.90% |
| Jun 30, 2021 | 15.42% |